Genexpath Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • M&A

Genexpath General Information

Description

Operator of a diagnostic platform designed to detect and treat cancer. The company designs new-generation diagnostic tests to better characterize cancers such as non-Hodgkin lymphomas and sarcomas, and develops and markets innovative tests based on next-generation sequencing to better characterize cancers, enabling medical professionals to establish quick diagnoses and improve patient care.

Contact Information

Website
www.genexpath.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 113 Avenue des Martyrs de la Résistance
  • 76100 Rouen
  • France
+33 02
Primary Industry
Diagnostic Equipment
Other Industries
Outcome Management (Healthcare)
Parent Company
CliniSciences
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 113 Avenue des Martyrs de la Résistance
  • 76100 Rouen
  • France
+33 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genexpath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 29-Jul-2025 Completed Generating Revenue
5. Seed Round 08-Jul-2024 Completed Generating Revenue
4. Accelerator/Incubator 04-Dec-2023 Completed Generating Revenue
3. Seed Round 29-Jul-2022 Completed Generating Revenue
2. Angel (individual) 21-Dec-2021 $115K $115K Completed Startup
1. Accelerator/Incubator 27-Nov-2020 Completed Startup
To view Genexpath’s complete valuation and funding history, request access »

Genexpath Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 34,000 $1.074613 $3.22 $3.22 1x $3.22 8.46%
To view Genexpath’s complete cap table history, request access »

Genexpath Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genexpath Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angels Santé Angel Group Minority
Link Tribe Capital Impact Investing Minority
Matwin Accelerator/Incubator
Normandie Incubation Accelerator/Incubator
To view Genexpath’s complete investors history, request access »

Ready to get started?

Request a free trial

Genexpath FAQs

  • When was Genexpath founded?

    Genexpath was founded in 2020.

  • Where is Genexpath headquartered?

    Genexpath is headquartered in Rouen, France.

  • What is the size of Genexpath?

    Genexpath has 4 total employees.

  • What industry is Genexpath in?

    Genexpath’s primary industry is Diagnostic Equipment.

  • Is Genexpath a private or public company?

    Genexpath is a Private company.

  • What is Genexpath’s current revenue?

    The current revenue for Genexpath is .

  • How much funding has Genexpath raised over time?

    Genexpath has raised $814K.

  • Who are Genexpath’s investors?

    Angels Santé, Link Tribe Capital, Matwin, and Normandie Incubation have invested in Genexpath.

  • When was Genexpath acquired?

    Genexpath was acquired on 29-Jul-2025.

  • Who acquired Genexpath?

    Genexpath was acquired by CliniSciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process